Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Ann Rheum Dis. 2012 Jan 20;71(7):1157–1162. doi: 10.1136/annrheumdis-2011-200493

Figure 2.

Figure 2

MPO activity, HDL antioxidant function and paraoxonase-1 activity in patients with RA compared to healthy controls. (A) Plasma MPO activity, (B) HDL antioxidant function (measured by the HDL inflammatory index (HII)) and (C) paraoxonase (PON-1) activity.